Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eyepoint Pharmaceuticals Inc
(NQ:
EYPT
)
8.950
+0.230 (+2.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eyepoint Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today
May 03, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q1 revenues of $7.68 million, down from $9.3 million a year ago but slightly
Via
Benzinga
EyePoint Pharmaceuticals: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments
May 02, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
Earnings Preview: EyePoint Pharmaceuticals
March 01, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday
April 24, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
April 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...
Via
Benzinga
EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21
April 21, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
April 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
Eyepoint Pharmaceuticals Inc. (NASDAQ: EYPT) Leading the Way in Monday Trading Based on Percentage Gain
March 27, 2023
Via
Investor Brand Network
Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout
March 16, 2023
Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.
Via
Benzinga
EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024
March 02, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
December 28, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
December 23, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
December 16, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, BRP, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm
December 12, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, BRP, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm
December 02, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Establishment and Encourages Investors to Contact the Firm
November 21, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Intuit and Encourages Investors to Contact the Firm
November 11, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, EyePoint, Spectrum, and F45 Training and Encourages Investors to Contact the Firm
November 06, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
NASDAQ:EYPT Investor Alert: Investigation over Potential Securities Laws Violations by EyePoint Pharmaceuticals, Inc.
November 02, 2022
San Diego, CA -- (SBWIRE) -- 11/02/2022 -- EyePoint Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
EyePoint Pharmaceuticals: Q3 Earnings Insights
November 02, 2022
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.